crypto if, Knowledge

The total output of automobiles in Shenzhen is expected to exceed 2.8 million vehicles this year. Last year, Shenzhen ranked among the "First City of New Energy Vehicles in China" with an output of 1.733 million vehicles. This year, the total output is expected to exceed 2.8 million vehicles, and it is expected to win the title of "First City of Automobile in China" again. (released by Shenzhen)Shanxi Securities: Sora officially launched the AI video generation tool, which continued to iterate. Shanxi Securities Research Report pointed out that 1) On December 10th, OpenAI officially launched Sora. Compared with the version released by OpenAI in February, the new Sora launched this time added Storyboard, Remix, Re-cut and other functions, which greatly improved the video re-creation ability and optimized the video generation speed and generation method. 2) Since the beginning of this year, domestic enterprises have begun to accelerate the research and development and iteration of AI video generation products, and the product capabilities have been continuously improved and the application scenarios have been continuously broadened. Sora was officially launched, and the video creation ability was significantly improved, and it began to change from a creative tool to a productivity tool. With the continuous iteration of AI video generation tools represented by Sora, its penetration into various application scenarios is expected to accelerate in the future. On the one hand, the application layer suggests focusing on creative, design, education and other multi-modal fields, especially video generation. On the other hand, the demand for computing power in video generation model is significantly higher than that in text, focusing on AI computing power related targets.HKEx: The database of integrated fund platform funds was launched, and the database of integrated fund platform funds was announced by HKEx, covering more than 2,000 funds approved by the Hong Kong Securities Regulatory Commission, aiming at improving the information transparency of Hong Kong fund investment products.

Microsoft: The latest small language model PHI-4, which is specially used for complex reasoning, is introduced.Bestak: Actively deploy the C-end smart product business. At present, it has not cooperated with Bean Bag AI. Bestak said at the performance briefing on December 12 that on the one hand, the company actively deployed the C-end smart product business, exerted its own brand, promoted business expansion with category innovation, and continuously enhanced the strategic value of the new development pattern. On the other hand, the company invested in the layout of cross-border e-commerce companies, and joined hands with them to promote the series of inflator products to the sea, strengthen the cross-border e-commerce coordination strategy, and vigorously explore the potential market. In addition, the company said that the company has not cooperated with Bean Bag AI at present.The three major stock indexes opened lower and went lower. The Shenzhen Stock Exchange Index and the Growth Enterprise Market Index all fell more than 1%, and the Shanghai Composite Index fell 0.88%.

Guojin Securities: The warm wind of medical policy comes first, then the progress of innovation going out to sea, and then the opportunity of performance reversal. Guojin Securities Research Report said that the core investment opportunities in the pharmaceutical sector in 25 years will revolve around three logics: 1) innovation going out to sea; 2) demand recovery; 3) Policy expectation reversal. At present, the policy warm wind comes first (the medical track policy continues to warm up, and the overall industry expectation is expected to be optimistic); Then, R&D and innovation will go to sea (innovative drug track will continue to make progress, and it will still be the hottest track in the pharmaceutical sector in 2025, especially it is recommended to pay attention to the clinical data reading and commercialization progress of the first-line target, as well as the fluctuation opportunity of the expected difference of the second-line innovative drugs), and then the performance growth rate is expected to bottom out in the first half of 2025 (but it will take time for this improvement in performance growth rate to come. Considering the current industry communication and historical base, it is expected that 4Q24 and 1Q25 should still be cautiously optimistic.)Treasury bond futures opened, with 30-year main contracts rising by 0.48%, 10-year main contracts rising by 0.36%, 5-year main contracts rising by 0.25% and 2-year main contracts rising by 0.05%.Shanghai Securities: The pharmaceutical and bio-industry is expected to further repair its performance and valuation. The Shanghai Securities Research Report pointed out that with the support of policies and the adjustment of the internal structure of the industry, the pharmaceutical and bio-industry is expected to further repair its performance and valuation. It is suggested to pay attention to five directions: 1) Innovative drugs (with strong national policy support, the payment terminal is expected to further improve and go to sea to occupy the global market); 2)CXO (the negative impact of the biosafety bill event has been eliminated, and the demand for orders in the superimposed interest rate reduction cycle has increased, which is expected to usher in a double repair of performance and valuation); 3) Imitation and innovation (centralized procurement is expected to clear up, increase innovation, and traditional pharmaceutical companies will usher in new opportunities); 4) Traditional Chinese Medicine (the national policy supports the innovation of traditional Chinese medicine, and its performance is expected to maintain a good growth rate); 5) Medical devices (equipment updating, high-consumption innovation, low-consumption going to sea, etc.). Individual stocks can be concerned about: Baekje Shenzhou, Wuxi PharmaTech, China Resources Sanjiu and so on.